NO975704D0 - (R)-(Z)-1-Azabicyklo£2.2.1|heptan-3-on,o-£3-(3-metoksyfenyl)-2-propynyl|oksim-maleat som et farmasöytisk middel - Google Patents

(R)-(Z)-1-Azabicyklo£2.2.1|heptan-3-on,o-£3-(3-metoksyfenyl)-2-propynyl|oksim-maleat som et farmasöytisk middel

Info

Publication number
NO975704D0
NO975704D0 NO975704A NO975704A NO975704D0 NO 975704 D0 NO975704 D0 NO 975704D0 NO 975704 A NO975704 A NO 975704A NO 975704 A NO975704 A NO 975704A NO 975704 D0 NO975704 D0 NO 975704D0
Authority
NO
Norway
Prior art keywords
heptan
azabicyclo
propynyl
methoxyphenyl
pharmaceutical
Prior art date
Application number
NO975704A
Other languages
English (en)
Other versions
NO975704L (no
NO308901B1 (no
Inventor
Howard Yoshihisa Ando
Stephen Douglas Barrett
Juan Carlos Jaen
Steven Edward Rose
Haile Tecle
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO975704D0 publication Critical patent/NO975704D0/no
Publication of NO975704L publication Critical patent/NO975704L/no
Publication of NO308901B1 publication Critical patent/NO308901B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO975704A 1995-06-07 1997-12-05 Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen NO308901B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/474,622 US5534522A (en) 1995-06-07 1995-06-07 (R)-(Z)-1-azabicyclo [2.2.1] heptan-3-one,O-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent
PCT/US1996/006814 WO1996040687A1 (en) 1995-06-07 1996-05-13 (r)-(z)-1-azabicyclo[2.2.1]heptan-3-one,o-[3-(3-methoxyphenyl)-2-propynyl]oxime maleate as a pharmaceutical agent

Publications (3)

Publication Number Publication Date
NO975704D0 true NO975704D0 (no) 1997-12-05
NO975704L NO975704L (no) 1998-01-30
NO308901B1 NO308901B1 (no) 2000-11-13

Family

ID=23884337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO975704A NO308901B1 (no) 1995-06-07 1997-12-05 Farmasøytisk aktiv forbindelse i form av (R)-(Z)-1- azabicyklo[2.2.1]heptan-3-on,O-[3-(3-metoksyfenyl)-2- propynyl]oksim-maleat, farmasøytisk preparat omfattende denne, samt anvendelse av forbindelsen

Country Status (24)

Country Link
US (1) US5534522A (no)
EP (1) EP0839148B1 (no)
JP (1) JPH11506723A (no)
KR (1) KR100383031B1 (no)
CN (1) CN1063181C (no)
AT (1) ATE187967T1 (no)
BG (1) BG63571B1 (no)
CA (1) CA2219753A1 (no)
CZ (1) CZ286528B6 (no)
DE (1) DE69605800T2 (no)
DK (1) DK0839148T3 (no)
EA (1) EA000381B1 (no)
EE (1) EE03971B1 (no)
ES (1) ES2142586T3 (no)
GE (1) GEP19991874B (no)
GR (1) GR3032772T3 (no)
HU (1) HUP9802499A3 (no)
NO (1) NO308901B1 (no)
NZ (1) NZ307946A (no)
PL (1) PL323796A1 (no)
SK (1) SK282824B6 (no)
UA (1) UA46032C2 (no)
WO (1) WO1996040687A1 (no)
ZA (1) ZA964764B (no)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9601909A (pt) * 1995-07-13 1999-10-13 Smithkline Beecham Corp N,n-dietil-8,8-dipropil-2-azaspiro(4,5)decano-2-propan amina dimaleato
US6528529B1 (en) 1998-03-31 2003-03-04 Acadia Pharmaceuticals Inc. Compounds with activity on muscarinic receptors
US7544681B2 (en) 2001-09-27 2009-06-09 Ramot At Tel Aviv University Ltd. Conjugated psychotropic drugs and uses thereof
EP1670785B1 (en) * 2003-10-02 2010-07-07 Pharmacia & Upjohn Company LLC Salts and polymorphs of a pyrrole-substituted indolinone compound
US7741358B2 (en) * 2005-04-14 2010-06-22 N.V. Organon Crystal form of asenapine maleate
JP5284779B2 (ja) * 2005-06-07 2013-09-11 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド コンジュゲート化された向精神薬の新規な塩およびその調製方法
EP2258358A3 (en) 2005-08-26 2011-09-07 Braincells, Inc. Neurogenesis with acetylcholinesterase inhibitor
EP1928437A2 (en) * 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2051735B1 (en) 2006-07-17 2012-08-29 Ramot, at Tel Aviv University Ltd. Conjugates comprising a psychotropic drug or a gaba agonist and an organic acid and their use treating pain and other cns disorders
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2009101616A1 (en) 2008-02-11 2009-08-20 Ramot At Tel Aviv University Ltd. Novel conjugates for treating neurodegenerative diseases and disorders
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011070579A1 (en) 2009-12-09 2011-06-16 Biolinerx Ltd. Methods of improving cognitive functions
US8377929B2 (en) 2010-02-24 2013-02-19 Ramot At Tel-Aviv University Ltd. Crystalline forms of the tri-mesylate salt of perphenazine-GABA and process of producing the same
WO2012038963A1 (en) 2010-09-22 2012-03-29 Ramot At Tel-Aviv University Ltd. An acid addition salt of a nortriptyline-gaba conjugate and a process of preparing same
JP5997931B2 (ja) * 2011-05-25 2016-09-28 石原産業株式会社 農園芸用殺菌剤組成物及び植物病害の防除方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5346911A (en) * 1990-03-06 1994-09-13 Warner-Lambert Company Azabicyclo and azacyclo oxime and amine cholinergic agents and methods of treatment
US5306718A (en) * 1990-03-06 1994-04-26 Warner-Lambert Company Oxime and amine substituted azabicyclo and azocyclo muscarinic agonists and methods of treatment

Also Published As

Publication number Publication date
EA199800007A1 (ru) 1998-06-25
CZ381797A3 (cs) 1998-05-13
HK1018055A1 (en) 1999-12-10
HUP9802499A3 (en) 1999-06-28
KR19990022572A (ko) 1999-03-25
ES2142586T3 (es) 2000-04-16
BG102078A (en) 1998-11-30
NO975704L (no) 1998-01-30
US5534522A (en) 1996-07-09
CN1186493A (zh) 1998-07-01
DE69605800T2 (de) 2000-11-16
BG63571B1 (bg) 2002-05-31
AU5744996A (en) 1996-12-30
AU697954B2 (en) 1998-10-22
CZ286528B6 (cs) 2000-05-17
GEP19991874B (en) 1999-12-06
CA2219753A1 (en) 1996-12-19
SK164497A3 (en) 1998-06-03
KR100383031B1 (ko) 2003-10-17
SK282824B6 (sk) 2002-12-03
DK0839148T3 (da) 2000-05-22
JPH11506723A (ja) 1999-06-15
PL323796A1 (en) 1998-04-27
NZ307946A (en) 2001-03-30
UA46032C2 (uk) 2002-05-15
NO308901B1 (no) 2000-11-13
EE9700316A (et) 1998-06-15
EA000381B1 (ru) 1999-06-24
WO1996040687A1 (en) 1996-12-19
HUP9802499A2 (hu) 1999-04-28
DE69605800D1 (de) 2000-01-27
GR3032772T3 (en) 2000-06-30
EE03971B1 (et) 2003-02-17
EP0839148B1 (en) 1999-12-22
CN1063181C (zh) 2001-03-14
EP0839148A1 (en) 1998-05-06
ZA964764B (en) 1997-01-08
ATE187967T1 (de) 2000-01-15

Similar Documents

Publication Publication Date Title
NO975704L (no) (R)-(Z)-1-Azabicyklo£2.2.1|heptan-3-on,o-£3-(3-metoksyfenyl)-2-propynyl|oksim-maleat som et farmasöytisk middel
CA2320224A1 (en) Method for modulating macrophage activation
AU6166996A (en) Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-((aminoiminomethyl)phenylalkyl)- azaheterocyclylamide compounds
CA2333004A1 (en) Formoterol polymorphs
BR9810623B1 (pt) processo para a preparação de um sal de tartarato de um dipeptìdeo substituìdo como secretagogo de hormÈnio do crescimento, misturas enantioméricas ou seus enantiÈmeros, sal e composto.
CA2356300A1 (en) 3-azabicyclo[3.1.0]hexane derivatives useful in therapy
CA2243542A1 (en) Resolution of threo-methylphenidate
FI911083A7 (fi) Menetelmä kolinergisina aineina käyttökelpoisten 1-atsabisyklo/2.2.1/heptaani- tai -/2.2.2/oktaani-3-oni-O-oksiimien valmistamiseksi
CA2155323A1 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
PT91302A (pt) Processo para a preparacao de composicoes farmaceuticas contendo imidazo {2,1-a} isoquinolinas substituidas por 5-heteroarilo ou 5-arilo
CA2170645A1 (en) Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-14-indole-5-ethanesulphonamide
CA2346171A1 (en) Uses of 1-amino-3-(n,n-dimethylamino)-propylidene-1,1-bisphosphonic acid
GB9815910D0 (en) Synthetic method
RU95107655A (ru) Глюкопиранозидбензотиофены, способ получения, фармацевтическая композиция
EP1026162A4 (en) ANTI-RHUMATISMAL AGENT
MX9708337A (es) Maleato (r)-(z)-1-azabiciclo [2.2.1]heptan-3-one,0-[3-(3-metoxifenil)-2-propinil]-oxime como un agente farmaceutico.
TNSN99035A1 (fr) NOUVEAUX PROCEDES POUR LA PREPARATION DE (R) - α - ( 2,3 DIMETHOXYPHENYL) -1 - [ 2 - (4 - FLUOROPHENYL) ETHYL] - 4 - PIPERIDINEMETHANOL
CA2360894A1 (en) (1-phenacyl-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
NO175565C (no) Fremgangsmåte for fremstilling av et parenteralt anvendbart, farmasöytisk preparat inneholdende et bis-indolalkaloid
AU3266893A (en) 3,4'-dideoxymycaminosyltylonolide derivative and production thereof
CA2279796A1 (en) Process for the preparation of substituted pyridines
CA2031578A1 (en) Process for the preparation of molluscicidal 2,4,5-tribromopyrrole-3-carbonitrile compounds
CA2352564A1 (en) Use of effectors of the central cholinergic nervous system
CA2261706A1 (en) The use of growth factor modulating compounds
HK1018055B (en) (r)-(z)-1-azabicyclo[2,2,1]heptan-3-one, o-[3-(3-methoxyphenyl)-2-propynyl] oxime maleate as a pharmaceutical agent

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees